4-Aminoisoquinoline - China Manufacturers, Suppliers, Factory

4-Aminoisoquinoline, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

4-Aminoisoquinoline CAS 23687-25-4 Purity 97.0 (HPLC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4-Aminoisoquinoline CAS 23687-25-4 Purity >97.0% (HPLC)
Read More

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.12.05 23:58:26
2022.09.23 11:34:25
2022.05.11 21:51:05
2022.04.09 20:30:30
2022.02.20 02:55:19
2022.01.06 07:57:17

4-Aminoisoquinoline - China Manufacturers, Suppliers, Factory

Related Products

4-Aminoisoquinoline CAS 23687-25-4 Purity >97.0% (HPLC)

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

2-Aminoquinoline CAS 580-22-3 Purity >97.0% (GC)(T)

H-D-Ala-OMe·HCl CAS 14316-06-4 D-Alanine Methyl Ester Hydrochloride Assay >99.0% (TLC)

6-Chlorooxindole CAS 56341-37-8 Purity >99.0% Ziprasidone Hydrochloride Intermediate Factory

Fmoc-Lys(Z)-OH CAS 86060-82-4 Purity >98.5% (HPLC)

3-Ethoxyacryloyl Chloride CAS 6191-99-7 Purity >97.0% (GC)

2-Acetylphenothiazine CAS 6631-94-3 Purity >98.5% (GC) High Quality

3-Ethylphenylboronic Acid CAS 90555-65-0 Purity >99.0% (HPLC) Factory High Quality

Aminoacetaldehyde Dimethyl Acetal CAS 22483-09-6 Purity >99.0% (GC) Factory Main Product

D-(-)-Lysine Monohydrochloride CAS 7274-88-6 H-D-Lys-OH·HCl Assay 98.5~100.5% Factory

MES CAS 4432-31-9 Purity ≥99.50% (Titration) Biological Buffer Ultra Pure Grade Factory

4-[N,N-Bis(2-hydroxyethyl)amino]benzaldehyde CAS 27913-86-6

Methyl Indole-7-Carboxylate CAS 93247-78-0 Purity >99.0% (HPLC) Factory High Quality

Paxlovid: what we know about Pfizer's Covid-19 pill

The “Summit on COVID-19 Diagnostics & Treatment”

New COVID treatments offer hope

Method Of Analyzing Palladium Content In Palladium Catalysts

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

2022.12.05 23:58:26

2022.09.23 11:34:25

2022.05.11 21:51:05

2022.04.09 20:30:30

2022.02.20 02:55:19

2022.01.06 07:57:17

related search